Medium Spiny Neurons (MSNs) represent a prominent neuronal subtype primarily found in the striatum, a key component of the brain's basal ganglia. Characterized by their distinctive morphology and sensitivity to dopamine, MSNs play a central role in motor control, reward processing, and habit formation. They are classified into two main subtypes based on their projection targets: those projecting to the internal globus pallidus (direct pathway) and those projecting to the external globus pallidus via the indirect pathway. The balance between these pathways is crucial for modulating movement and preventing unwanted actions. MSNs receive input from various brain regions, including the cortex and thalamus, forming complex neural circuits. Dysregulation of MSN activity has been implicated in neurodegenerative disorders such as Parkinson's disease and Huntington's disease. Studying the physiology and connectivity of medium spiny neurons provides valuable insights into the neural mechanisms underlying motor control and reward-based learning. Ongoing research aims to unravel the intricacies of MSN function, exploring potential therapeutic targets for neurological conditions associated with basal ganglia dysfunction.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy